Table 3.

IQOL Scores (Secondary Outcome) for Women Who Underwent RF Treatment and Sham, at Before Treatment, 1 Month Follow Up, 3 Month Follow Up, 6 Month Follow Up, and 12 Month Follow Up, Compared Between RF Treatment and Sham Control Groups

	Treatment Group	Sham Group	Comparison
	IQOL Scores (95% CI)	IQOL Scores (95% CI)	Mean Difference (95% CI)	p-value
Baseline	60.95 (51.66–70.24)	65.35 (56.61–74.09)	−4.40 (−17.16–8.35)	0.49
1 month follow up	75.18 (65.48–84.87)	79.61 (70.50–88.73)	−4.43 (−17.74–8.86)	0.51
3 month follow up	79.41 (69.71–89.19)	78.15 (69.03–87.26)	1.26 (−12.05–14.57)	0.85
6 month follow up	79.21 (69.52–88.90)	78.77 (69.66–87.89)	0.43 (−12.87–13.74)	0.95
12 month follow up	70.40 (60.70–80.09)	69.09 (59.97–78.21)	1.30 (−12.00–14.61)	0.85